Chile said that people that received AstraZeneca’s COVID-19 shot should get their second dose, but health officials put a new limit on the age of recipients until an investigation into possible complications is completed, reported Reuters.
Chilean health ministry said a 31-year-old man had developed thrombosis with thrombocytopenia syndrome (TTS) seven days after his first AstraZeneca vaccine shot.
According to Reuters, the government then raised the minimum age of men eligible to receive the vaccine to 45 years. Chilean regulators initially approved AstraZeneca’s vaccine for men over 18 and women over 45, according to Reuters.
Meanwhile, Argentina began to produce Russia’s Sputnik V, according to the Russian state TV channel Rossiya 24.